Jane Street
CPIX icon

Jane Street’s Cumberland Pharmaceuticals CPIX Stock Holding History

Jane Street’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.6K Buy
+12,800
New +$49.3K ﹤0.01% 11030

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Jane Street's CPIX Position: Q1 2026 in Review

Jane Street opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 14,607 shares worth $47.5K. The stake represents ﹤0.01% of the portfolio and ranks #10988 among its holdings. This is a return to the name: Jane Street previously reported a position in CPIX as recently as Q2 2013.

Jane Street first reported a position in CPIX in Q2 2013 and has held it in 2 quarters since. The position peaked at $85K in Q2 2013. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.

  • Jane Street held 14,607 shares of Cumberland Pharmaceuticals worth $47.5K as of Q1 2026.
  • Cumberland Pharmaceuticals was a new Jane Street position in Q1 2026.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10988 holding.
  • Jane Street first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • Jane Street's Cumberland Pharmaceuticals position peaked at $85K in Q2 2013.
  • 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.